170 related articles for article (PubMed ID: 28347253)
21. Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: Enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells.
Huang WT; Larsson M; Lee YC; Liu DM; Chiou GY
Eur J Pharm Biopharm; 2016 Dec; 109():165-173. PubMed ID: 27793756
[TBL] [Abstract][Full Text] [Related]
22. Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro.
Tan YL; Liu CG
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):178-82. PubMed ID: 19124228
[TBL] [Abstract][Full Text] [Related]
23. Carboxymethyl gum kondagogu-chitosan polyelectrolyte complex nanoparticles: preparation and characterization.
Kumar A; Ahuja M
Int J Biol Macromol; 2013 Nov; 62():80-4. PubMed ID: 23994791
[TBL] [Abstract][Full Text] [Related]
24. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticles Targeted against Cryptococcal Pneumonia by Interactions between Chitosan and Its Peptide Ligand.
Tang Y; Wu S; Lin J; Cheng L; Zhou J; Xie J; Huang K; Wang X; Yu Y; Chen Z; Liao G; Li C
Nano Lett; 2018 Oct; 18(10):6207-6213. PubMed ID: 30260652
[TBL] [Abstract][Full Text] [Related]
26. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
[TBL] [Abstract][Full Text] [Related]
27. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
[TBL] [Abstract][Full Text] [Related]
28. Assessment of sequential combination of 5-fluorouracil-loaded-chitosan-nanoparticles and ALA-photodynamic therapy on HeLa cell line.
Benito-Miguel M; Blanco MD; Gómez C
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):466-75. PubMed ID: 25976508
[TBL] [Abstract][Full Text] [Related]
29. Targeted delivery of vaccine to dendritic cells by chitosan nanoparticles conjugated with a targeting peptide ligand selected by phage display technique.
Jung SN; Kang SK; Yeo GH; Li HY; Jiang T; Nah JW; Bok JD; Cho CS; Choi YJ
Macromol Biosci; 2015 Mar; 15(3):395-404. PubMed ID: 25393207
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro evaluation of carboxymethyl starch-chitosan nanoparticles as drug delivery system to the colon.
Saboktakin MR; Tabatabaie RM; Maharramov A; Ramazanov MA
Int J Biol Macromol; 2011 Apr; 48(3):381-5. PubMed ID: 20955728
[TBL] [Abstract][Full Text] [Related]
31. [Effect of peptide seals specific to CD59 on the expression of apoptosis-related genes in HeLa cells].
Li XP; Gao MH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):20-2. PubMed ID: 18177611
[TBL] [Abstract][Full Text] [Related]
32. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery.
Meng D; Guo L; Shi D; Sun X; Shang M; Zhou X; Li J
Nanomedicine (Lond); 2019 Oct; 14(19):2549-2565. PubMed ID: 31271101
[No Abstract] [Full Text] [Related]
33. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.
Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O
Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230
[TBL] [Abstract][Full Text] [Related]
34. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles.
Zu Y; Zhang Y; Wang W; Zhao X; Han X; Wang K; Ge Y
Drug Deliv; 2016; 23(3):981-91. PubMed ID: 24918466
[TBL] [Abstract][Full Text] [Related]
35. Novel carboxymethyl chitosan-graphene oxide hybrid particles for drug delivery.
Shi Y; Xiong Z; Lu X; Yan X; Cai X; Xue W
J Mater Sci Mater Med; 2016 Nov; 27(11):169. PubMed ID: 27709459
[TBL] [Abstract][Full Text] [Related]
36. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
37. Preparation of biocompatible carboxymethyl chitosan nanoparticles for delivery of antibiotic drug.
Zhao L; Zhu B; Jia Y; Hou W; Su C
Biomed Res Int; 2013; 2013():236469. PubMed ID: 23586023
[TBL] [Abstract][Full Text] [Related]
38. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
39. Targeted delivery of a novel anticancer compound anisomelic acid using chitosan-coated porous silica nanorods for enhancing the apoptotic effect.
Senthilkumar R; Karaman DŞ; Paul P; Björk EM; Odén M; Eriksson JE; Rosenholm JM
Biomater Sci; 2015 Jan; 3(1):103-11. PubMed ID: 26214194
[TBL] [Abstract][Full Text] [Related]
40. The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.
Wong CY; Al-Salami H; Dass CR
J Drug Target; 2018 Aug; 26(7):551-562. PubMed ID: 29095650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
